Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome

Psychoneuroendocrinology

Volumn 36, Issue 4, 2011, Pages 523-530

  Cubeddu, Alessandra ^a   Bucci, Fiorella ^a   Giannini, Andrea ^a   Russo, Marinella ^a   Daino, Diana ^a   Russo, Natalia ^a   Merlini, Sara ^a   Pluchino, Nicola ^a   Valentino, Valeria ^a   Casarosa, Elena ^a   Luisi, Stefano ^b   Genazzani, Andrea Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Brain derived neurotrophic factor; Menstrual cycle; Premenstrual syndrome; Sex hormones

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ESTRADIOL; PROGESTERONE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARY CYCLE; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; OSMOLAR CONCENTRATION; PREMENSTRUAL SYNDROME; PROGESTERONE; TIME FACTORS; YOUNG ADULT;

EID: 79952040663     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.08.006     Document Type: Article

References (65)

1. ACOG ACOG practice bulletin: premenstrual syndrome. Int. J. Gynecol. Obstetr. 2001, 73:183-191.
2. Andréen L., Nyberg S., Turkmen S., van Wingen G., Fernández G., Bäckström T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology 2009, 34:1121-1132.
3. Anger D.L., Zhang B., Boutross-Tadross O., Foster W.G. Tyrosine receptor kinase B (TrkB) protein expression in the human endometrium. Endocrine 2007, 31:167-173.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
5. Bäckström T., Andersson A., Andréen L., Birzniece V., Bixo M., Björn I., Haage D., Isaksson M., Johansson I.M., Lindblad C., Lundgren P., Nyberg S., Odmark I.S., Strömberg J., Sundström-Poromaa I., Turkmen S., Wahlström G., Wang M., Wihlbäck A.C., Zhu D., Zingmark E. Pathogenesis in menstrual cycle-linked CNS disorders. Ann. N.Y. Acad. Sci. 2003, 1007:42-53.
6. Barde Y.A. The nerve growth factor family. Prog. Growth Factor Res. 1990, 2:237-248.
7. Barde Y.A. Biological roles of neurotrophins. Neurotrophic Factors 1999, Springer Verlag, Berlin, Germany. F. Hefti (Ed.).
8. Begliuomini S., Casarosa E., Pluchino N., Lenzi E., Centofanti M., Freschi L., Pieri M., Genazzani A.D., Luisi S., Genazzani A.R. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum. Reprod. 2007, 22:995-1002.
9. Bekinschtein P., Cammarota M., Izquierdo I., Medina J.H. BDNF and memory formation and storage. Neuroscientist 2008, 14:147-156.
10. Bimonte-Nelson H.A., Nelson M.E., Granholm A.C. Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain. Neuroreport 2004, 15:2659-2663.
11. Bloch M., Schmidt P.J., Su T.P., Tobin M.B., Rubinow D.R. Pituitary-adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls. Biol. Psychiatry 1998, 43:897-903.
12. Blurton-Jones M., Kuan P.N., Tuszynski M.H. Anatomical evidence for transsynaptic influences of estrogen on brain-derived neurotrophic factor expression. J. Comp. Neurol. 2004, 468:347-360.
13. Connor B., Young D., Yan Q., Faull R.L., Synek B., Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res. Mol. Brain Res. 1997, 49:71-81.
14. Cubeddu A., Giannini A., Bucci F., Merlini S., Casarosa E., Pluchino N., Luisi S., Luisi M., Genazzani A.R. Paroxetine increases brain-derived neurotrophic factor in menopausal women. Menopause 2010, 17:338-343.
15. De Vane G.W. Premenstrual syndrome. J. Clin. Endocrinol. Metab. 1991, 72:250-251.
16. Eriksson E., Sundblad C., Lisjö P., Modigh K., Andersch B. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 1992, 17:195-204.
17. Genazzani A.R., Stomati M., Morittu A., Bernardi F., Monteleone P., Casarosa E., Gallo R., Salvestroni C., Luisi M. Progesterone, progestagens and the central nervous system. Hum. Reprod. 2000, 15:14-27.
18. Genazzani A.R., Pluchino N., Luisi S., Luisi M. Estrogen, cognition and female ageing. Hum. Reprod. Update 2007, 13:175-187.
19. Harel S., Jin S., Fisch B., Feldberg D., Krissi H., Felz C., Freimann S., Tan S.L., Ao A., Abir R. Tyrosine kinase B receptor and its activated neurotrophins in ovaries from human fetuses and adults. Mol. Hum. Reprod. 2006, 12:357-365.
20. Henderson C.E. Role of neurotrophic factors in neuronal development. Curr. Opin. Neurobiol. 1996, 6:64-70.
21. Hohlfeld R. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?. J. Neurol. Sci. 2008, 265:93-96.
22. Kang H., Schumann E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995, 267:1658-1662.
23. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 2002, 328:261-264.
24. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109:143-148.
25. Komulainen P., Pedersen M., Hänninen T., Bruunsgaard H., Lakka T.A., Kivipelto M., Hassinen M., Rauramaa T.H., Pedersen B.K., Rauramaa R. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA study. Neurobiol. Learn. Mem. 2008, 90:596-603.
26. Lang U.E., Hellweg R., Seifert F., Schubert F., Gallinat J. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol. Psychiatry 2007, 62:530-535.
27. Lee H.Y., Kim Y.K. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 2008, 57:194-199.
28. Lessmann V., Brigadski T. Mechanisms, locations, and kinetics of synaptic BDNF secretion: an update. Neurosci. Res. 2009, 65:11-22.
29. Liang F.Q., Walline R., Earnest D.J. Circadian rhythm of brain-derived neurotrophic factor in the rat suprachiasmatic nucleus. Neurosci. Lett. 1998, 242:89-92.
30. Lombardi I., Luisi S., Quirici B., Monteleone P., Bernardi F., Liut M., Casarosa E., Palumbo M., Petraglia F., Genazzani A.R. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Gynecol. Endocrinol. 2004, 18:79-87.
31. Lommatzsch M., Zingler D., Schuhbaeck K., Schloetcke K., Zingler C., Schuff-Werner P., Virchow J.C. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging 2005, 26:115-123.
32. McAllister A.K., Katz L.C., Lo D.C. Neurotrophins and synaptic plasticity. Annu. Rev. Neurosci. 1999, 22:295-318.
33. Meaden P.M., Hartlage S.A., Cook-Kerr J. Timing and severity of symptoms associated with the menstrual cycle in a community-based sample in the Midwestern United states. Psychiatry Res. 2005, 134:27-36.
34. Merighi A., Salio C., Ghirri A., Lossi L., Ferrini F., Betelli C., Bardoni R. BDNF as a pain modulator. Prog. Neurobiol. 2008, 85:297-317.
35. Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I.R., Schwartz M. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J. Autoimmun. 2000, 15:331-345.
36. Moalem G., Tracey D.J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. 2006, 51:240-264.
37. Monteleone P., Luisi S., Tonetti A., Bernardi F., Genazzani A.D., Luisi M., Petraglia F., Genazzani A.R. Allopregnanolone concentrations and premenstrual syndrome. Eur. J. Endocrinol. 2000, 142:269-273.
38. Monteleone P., Fabrazzo M., Martiadis V., Serritella C., Pannuto M., Maj M. Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder: relationships to co-morbid depression, psychopathology and hormonal variables. Psychol. Med. 2005, 35:897-905.
39. Murphy D.D., Cole N.B., Segal M. Brain-derived neurotrophic factor mediates estradiol-induced dendritic spine formation in hippocampal neurons. Proc Natl Acad Sci USA 1998, 95:11412-11417.
40. Naert G., Maurice T., Tapia-Arancibia L., Givalois L. Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats. Psychoneuroendocrinology 2007, 32:1062-1078.
41. Nakahashi T., Fujimura H., Altar C.A., Li J., Kambayashi J., Tandon N.N., Sun B. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett. 2000, 470:113-117.
42. Nakazato M., Hashimoto K., Shimizu E., Kumakiri C., Koizumi H., Okamura N., Mitsumori M., Komatsu N., Iyo M. Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol. Psychiatry 2003, 54:485-490.
43. Nyberg S., Wahlstrom G., Backstrom T., Sundstrom Poromaa I. Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual disphoric disorder. Psychoneuroendocrinology 2004, 6:767-777.
44. Palomino A., Vallejo-Illarramendi A., González-Pinto A., Aldama A., González-Gómez C., Mosquera F., González-García G., Matute C. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr. Res. 2006, 86:321-322.
45. Pan W., Banks W.A., Fasold M.B., Bluth J., Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998, 37:1553-1567.
46. Parain K., Murer M.G., Yan Q., Faucheux B., Hirsch Y., Raisman-Vozari R. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport 1999, 10:557-561.
47. Pelleymounter M.A., Cullen M.J., Wellman C.L. Characteristics of BDNF-induced weight loss. Exp. Neurol. 1995, 131:229-238.
48. Piccinni A., Marazziti D., Catena M., Domenici L., Del Debbio A., Bianchi C., Mannari C., Martini C., Da Pozzo E., Schiavi E., Mariotti A., Roncaglia I., Palla A., Consoli G., Giovannini L., Massimetti G., Dell'Osso L. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J. Affect. Disord. 2008, 105:279-283.
49. Pluchino N., Cubeddu A., Giannini A., Merlini S., Cela V., Angioni S., Genazzani A.R. Progestogens and brain: an update. Maturitas 2009, 62:349-355.
50. Pluchino N., Cubeddu A., Begliuomini S., Merlini S., Giannini A., Bucci F., Casarosa E., Luisi M., Cela V., Genazzani A.R. Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause. Hum. Reprod. 2009, 24:2303-2309.
51. Poduslo J.F., Curran G.L. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Mol. Brain Res. 1996, 36:280-286.
52. Scharfman H.E., MacLusky N.J. Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front. Neuroendocrinol. 2006, 27:415-435.
53. Seifer D.B., Lambert-Messerlian G., Schneyer A.L. Ovarian brain-derived neurotrophic factor is present in follicular fluid from normally cycling women. Fertil. Steril. 2003, 79:451-452.
54. Smith S.S., Ruderman Y., Frye C., Homanics G., et al. Steroid withdrawal in the mouse result in anxiogenic effects of 3alpha, 5beta-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology 2005, 29:1-11.
55. Sohrabji F., Miranda R.C.G., Toran-Allerand C.D. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:11110-11114.
56. Sohrabji F., Lewis D.K. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Rev. Front. Neuroendocrinol. 2006, 27:404-414.
57. Steiner M., Dunn E.J. The psychobiology of female specific mood disorders. Infertil. Reprod. Med. Clin. North. Am. 1996, 7:297-313.
58. Steiner M., Pearlstein T., Cohen L.S., Endicott J., Kornstein S.G., Roberts C., Roberts D.L., Yonkers K. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J. Womens Health (Larchmt). 2006, 15:57-69.
59. Sundstrom I., Ashbrock D., Backstrom T. Rediced benzodiazepine sensitività in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology 1997, 22:25-38.
60. Sundstrom Poromaa I., Smith G., Gulinello M. GABA receptors, progesterone and premenstrual dysphoric disorder. Arch. Womens Ment. Health 2003, 6:23-41.
61. Tapia-Arancibia L., Rage F., Givalois L., Arancibia S. Physiology of BDNF: focus on hypothalamic function. Rev. Front. Neuroendocrinol. 2004, 25:77-107.
62. Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T., Nawa H. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res. 2002, 110:249-257.
63. World Health Organization (WHO), 1996. Mental, behavioural and developmental disorders. In: International Classification of Diseases, 10th ed. (ICD-10). World Health Organization, Geneva.
64. Yonkers K.A., O'Brien P.M.S., Eriksson E. Premenstrual syndrome. Lancet 2008, 71:1200-1210.
65. Zafra F., Castrèn E., Thoenen H., Lindholm D. Interplay between glutamate and γ-aminobutirric acid transmitters systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:10037-10041.